Wilcken, B., Haas, M., Joy, P., Wiley, V., Bowling, F., Carpenter, K., Christodoulou, J., Cowley, D., Ellaway, C., Fletcher, J., Kirk, E., Lewis, B., McGill, J., Peters, H., Pitt, J., Ranieri, E., Yaplito-Lee, J., Boneh, A. (2009), Expanded Newborn Screening: Outcome in Screened and Unscreened Patients at Age 6 Years. Pediatrics. 124(2), e241-e248. [Abstract]
Knight, S., Northam, E., Donath, S., Gardner, A., Harkin, N., Taplin, C., Joy, P., Cameron, F., Ambler, G. (2009), Improvements in cognition, mood and behaviour following commencement of continuous subcutaneous insulin infusion therapy in children with type 1 diabetes mellitus: a pilot study. Diabetologia. 52(2), 193-198. [Abstract]
Norman, R., Haas, M., Chaplin, M., Joy, P., Wilcken, B. (2009), Economic evaluation of tandem mass spectrometry newborn screening in Australia. Pediatrics. 123(2), 451-457. [Abstract]
Joy, P., Black, C., Rocca, A., Haas, M., Wilcken, B. (2009), Neuropsychological functioning in children with medium chain acyl coenzyme a dehydrogenase deficiency (MCADD): The impact of early diagnosis and screening on outcome. Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence. 15(1), 8-20. [Abstract]
Haas, M., Chaplin, M., Joy, P., Wiley, V., Black, C., Wilcken, B. (2007), Healthcare use and costs of medium-chain acyl-CoA dehydrogenase deficiency in Australia: screening versus no screening. The Journal of pediatrics. 151(2), 121-126, 126.e1. [Abstract]
Schindeler, S., Ghosh-Jerath, S., Thompson, S., Rocca, A., Joy, P., Kemp, A., Rae, C., Green, K., Wilcken, B., Christodoulou, J. (2007), The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Molecular genetics and metabolism. 91(1), 48-54. [Abstract]
Wilcken, B., Haas, M., Joy, P., Wiley, V., Chaplin, M., Black, C., Fletcher, J., McGill, J., Boneh, A. (2007), Outcome of neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency in Australia: a cohort study. Lancet. 369(9555), 37-42. [Abstract]